BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29549174)

  • 1. Human CTL-based functional analysis shows the reliability of a munc13-4 protein expression assay for FHL3 diagnosis.
    Shibata H; Yasumi T; Shimodera S; Hiejima E; Izawa K; Kawai T; Shirakawa R; Wada T; Nishikomori R; Horiuchi H; Ohara O; Ishii E; Heike T
    Blood; 2018 May; 131(18):2016-2025. PubMed ID: 29549174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CD57
    Hori M; Yasumi T; Shimodera S; Shibata H; Hiejima E; Oda H; Izawa K; Kawai T; Ishimura M; Nakano N; Shirakawa R; Nishikomori R; Takada H; Morita S; Horiuchi H; Ohara O; Ishii E; Heike T
    J Clin Immunol; 2017 Jan; 37(1):92-99. PubMed ID: 27896523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative
    Galgano D; Soheili T; Voss M; Torralba-Raga L; Tesi B; Cichocki F; Andre I; Rettig J; Cavazzana M; Bryceson Y
    Front Immunol; 2020; 11():1154. PubMed ID: 32582217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, immunological and genetic findings in patients with UNC13D deficiency (FHL3): A systematic review.
    Amirifar P; Ranjouri MR; Abolhassani H; Moeini Shad T; Almasi-Hashiani A; Azizi G; Moamer S; Aghamohammadi A; Yazdani R
    Pediatr Allergy Immunol; 2021 Jan; 32(1):186-197. PubMed ID: 32679608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Founder effects in two predominant intronic mutations of UNC13D, c.118-308C>T and c.754-1G>C underlie the unusual predominance of type 3 familial hemophagocytic lymphohistiocytosis (FHL3) in Korea.
    Seo JY; Song JS; Lee KO; Won HH; Kim JW; Kim SH; Lee SH; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Han DK; Kook H; Hwang TJ; Lyu CJ; Lee MJ; Kim JY; Park SS; Lim YT; Kim BE; Koh KN; Im HJ; Seo JJ; Kim HJ;
    Ann Hematol; 2013 Mar; 92(3):357-64. PubMed ID: 23180437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical familial hemophagocytic lymphohistiocytosis type 3 in children: A report of cases and literature review.
    Zhao Q; Zhao Q; Tang X; An Y; Zhang Z; Tomomasa D; Hijikata A; Yang X; Kanegane H; Zhao X
    Pediatr Allergy Immunol; 2024 May; 35(5):e14136. PubMed ID: 38747707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a large UNC13D gene duplication in a patient with familial hemophagocytic lymphohistiocytosis type 3.
    Hiejima E; Shibata H; Yasumi T; Shimodera S; Hori M; Izawa K; Kawai T; Matsuoka M; Kojima Y; Ohara A; Nishikomori R; Ohara O; Heike T
    Clin Immunol; 2018 Jun; 191():63-66. PubMed ID: 29596912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 253-kb inversion and deep intronic mutations in UNC13D are present in North American patients with familial hemophagocytic lymphohistiocytosis 3.
    Qian Y; Johnson JA; Connor JA; Valencia CA; Barasa N; Schubert J; Husami A; Kissell D; Zhang G; Weirauch MT; Filipovich AH; Zhang K
    Pediatr Blood Cancer; 2014 Jun; 61(6):1034-40. PubMed ID: 24470399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid diagnosis of FHL3 by flow cytometric detection of intraplatelet Munc13-4 protein.
    Murata Y; Yasumi T; Shirakawa R; Izawa K; Sakai H; Abe J; Tanaka N; Kawai T; Oshima K; Saito M; Nishikomori R; Ohara O; Ishii E; Nakahata T; Horiuchi H; Heike T
    Blood; 2011 Aug; 118(5):1225-30. PubMed ID: 21653941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes.
    Nagai K; Yamamoto K; Fujiwara H; An J; Ochi T; Suemori K; Yasumi T; Tauchi H; Koh K; Sato M; Morimoto A; Heike T; Ishii E; Yasukawa M
    PLoS One; 2010 Nov; 5(11):e14173. PubMed ID: 21152410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral Gene Therapy for Familial Hemophagocytic Lymphohistiocytosis Type 3, Caused by
    Takushi SE; Paik NY; Fedanov A; Prince C; Doering CB; Spencer HT; Chandrakasan S
    Hum Gene Ther; 2020 Jun; 31(11-12):626-638. PubMed ID: 32253931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions.
    Ishii E; Ueda I; Shirakawa R; Yamamoto K; Horiuchi H; Ohga S; Furuno K; Morimoto A; Imayoshi M; Ogata Y; Zaitsu M; Sako M; Koike K; Sakata A; Takada H; Hara T; Imashuku S; Sasazuki T; Yasukawa M
    Blood; 2005 May; 105(9):3442-8. PubMed ID: 15632205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL).
    Ueda I; Ishii E; Morimoto A; Ohga S; Sako M; Imashuku S
    Pediatr Blood Cancer; 2006 Apr; 46(4):482-8. PubMed ID: 16365863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D.
    Meeths M; Chiang SC; Wood SM; Entesarian M; Schlums H; Bang B; Nordenskjöld E; Björklund C; Jakovljevic G; Jazbec J; Hasle H; Holmqvist BM; Rajic L; Pfeifer S; Rosthøj S; Sabel M; Salmi TT; Stokland T; Winiarski J; Ljunggren HG; Fadeel B; Nordenskjöld M; Henter JI; Bryceson YT
    Blood; 2011 Nov; 118(22):5783-93. PubMed ID: 21931115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Spectrum of Clinical, Immunological, and Molecular Findings in Familial Hemophagocytic Lymphohistiocytosis: Experience From India.
    Shabrish S; Kelkar M; Yadav RM; Bargir UA; Gupta M; Dalvi A; Aluri J; Kulkarni M; Shinde S; Sawant-Desai S; Kambli P; Hule G; Setia P; Jodhawat N; Gaikwad P; Dhawale A; Nambiar N; Gowri V; Pandrowala A; Taur P; Raj R; Uppuluri R; Sharma R; Kini P; Sivasankaran M; Munirathnam D; Vedam R; Vignesh P; Banday A; Rawat A; Aggarwal A; Poddar U; Girish M; Chaudhary A; Sampagar A; Jayaraman D; Chaudhary N; Shah N; Jijina F; Chandrakla S; Kanakia S; Arora B; Sen S; Lokeshwar M; Desai M; Madkaikar M
    Front Immunol; 2021; 12():612583. PubMed ID: 33746956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel Dutch mutation in UNC13D reveals an essential role of the C2B domain in munc13-4 function.
    Elstak ED; te Loo M; Tesselaar K; van Kerkhof P; Loeffen J; Grivas D; Hennekam E; Boelens JJ; Hoogerbrugge PM; van der Sluijs P; van Gijn ME; van de Corput L
    Pediatr Blood Cancer; 2012 Apr; 58(4):598-605. PubMed ID: 21755595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and atypical splicing mutation in a compound heterozygous UNC13D defect presenting in Familial Hemophagocytic Lymphohistiocytosis triggered by EBV infection.
    Alsina L; Colobran R; de Sevilla MF; Català A; Viñas L; Ricart S; Plaza AM; Lois S; Juan M; Pujol-Borrell R; Martinez-Gallo M
    Clin Immunol; 2014 Aug; 153(2):292-7. PubMed ID: 24825797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency.
    Cichocki F; Schlums H; Li H; Stache V; Holmes T; Lenvik TR; Chiang SC; Miller JS; Meeths M; Anderson SK; Bryceson YT
    J Exp Med; 2014 Jun; 211(6):1079-91. PubMed ID: 24842371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Hemophagocytic Lymphohistiocytosis secondary to UNC13D mutation: a report of two cases.
    Sadeghi P; Esslami GG; Rokni-Zadeh H; Changi-Ashtiani M; Mohsenipour R
    BMC Pediatr; 2022 Nov; 22(1):667. PubMed ID: 36401200
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Benavides N; Spessott WA; Sanmillan ML; Vargas M; Livingston MS; Erickson N; Pozos TC; McCormick ME; Scharrig E; Messinger YH; Giraudo CG
    Front Immunol; 2020; 11():545414. PubMed ID: 33162974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.